PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024 16:05 ET
|
PetIQ, Inc.
Record Full Year 2023 Net Sales Increase 19.6% Year-Over-Year to Over $1.1 BillionAdjusted EBITDA Exceeds Company's Full Year 2023 GuidanceReports Highest Annual Cash from Operations in the Company's...
MidCap Financial Investment Corporation Reports Financial Results for the Quarter and Fiscal Year Ended December 31, 2023
February 26, 2024 16:01 ET
|
MidCap Financial Investment Corporation
Results for the Quarter and Fiscal Year Ended December 31, 2023 and Other Recent Highlights: Net investment income per share for the quarter was $0.46, compared to $0.43 for the quarter ended...
Heineken N.V. reports 2023 full year results
February 14, 2024 01:00 ET
|
HEINEKEN NV
Amsterdam, 14 February 2024 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announces: Key Highlights Revenue €36,375 million, up 4.9%Net revenue (beia) 5.5%...
Collective Audience Appoints AdTech Executive, Inventor and Venture Investor, Joe Zawadzki, as Chairman
February 08, 2024 11:30 ET
|
Collective Audience, Inc.
He has played a crucial role in shaping the evolution of the industry, inventing the demand-side platform category with MediaMath
Spod Lithium Preparing Upcoming Drill Program Following Positive Results From Fall Prospecting
February 08, 2024 08:33 ET
|
Spod Lithium Corp.
Highlight Results from Spod Lithium’s Mega Li and La Grande 4 Properties Adjacent to Patriot Battery Metals Corvette Project in Quebec, Canada: Drilling targets are identified through surface...
H&R Block Announces Quarterly Cash Dividend
January 31, 2024 16:15 ET
|
HRB Tax Group, Inc.
KANSAS CITY, Mo., Jan. 31, 2024 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) (the “Company”) today announced that its Board of Directors declared a quarterly cash dividend of $0.32 cents per...
Longeveron Announces Additional Positive Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel-B™ in the Treatment of Mild Alzheimer’s Disease
December 20, 2023 08:00 ET
|
Longeveron
New clinical data showed that Lomecel-B™ improved cognitive function in multiple measures in a dose-response fashion Caregiver ratings documented improved quality of life in Lomecel-B™ treated...
Rubicon Organics Reports Third Quarter 2023 Financial Results
November 14, 2023 22:30 ET
|
Rubicon Organics
Net revenue of $10.0 million and $30.1 million for the three and nine months ended September 30, 2023Adjusted EBITDA1 of $1.1 million and $3.1 million for the three and nine months ended September 30,...
Longeveron Reports Third Quarter 2023 Results and Provides Corporate Update
November 10, 2023 07:30 ET
|
Longeveron
Top Line Results from CLEAR MIND Alzheimer’s disease Trial Affirm Safety Profile of Lomecel-B™ and Provide Efficacy Signal; Full Study Data Remains on Track to Share in Coming Weeks Long-term...
MidCap Financial Investment Corporation Reports Financial Results for the Quarter Ended September 30, 2023 and Announces Merger Agreements with Apollo Senior Floating Rate Fund Inc. and Apollo Tactical Income Fund Inc.
November 07, 2023 15:08 ET
|
MidCap Financial Investment Corporation
Results for the Quarter Ended September 30, 2023 and Other Recent Highlights: Net investment income per share for the quarter was $0.43, compared to $0.44 for the quarter ended June 30, 2023 Net...